Medicare Compliance & Reimbursement

Hospice:

Watch Out for Regulatory and Compliance Hot Spots

Will your documentation pass muster?

The Centers for Medicare & Medicaid Services (CMS) outlines plans for some big changes in the proposed rule for 2017 hospice payment. Chief among them are new quality measures and a new OASIS-like assessment tool.

Good news: Some of the big hospice data points CMS and its contractors are tracking have gone down, points out Judi Lund Person with the National Hospice & Palliative Care Organization. For example, these figures have all decreased: percentage of claims with only one diagnosis; non-hospice spending for hospice patients; Part D spending on drugs for hospice patients; and live discharges.

Bad news: But it appears to be too little, too late. CMS spends a big chunk of the proposed rule outlining its concerns with various areas and warning hospices that it will be monitoring the data and planning related action.

“The greatest risk for hospice agencies … is not necessarily one of the proposals in the rule, but rather the warnings from CMS that it suspects certain hospice providers of engaging in widespread fraudulent activity,” says RN Beth Noyce with Noyce Consulting in Salt Lake City.

Watch out: Providers whose data sticks out in CMS’s areas of concern will most likely “eventually face provider-specific reviews,” Noyce expects. “My concern is that much hospice clinical documentation may not pass muster under medical review.”

Other Articles in this issue of

Medicare Compliance & Reimbursement

View All